Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.

Autor: Oe, Yuki1 (AUTHOR), Nomoto, Hiroshi1 (AUTHOR), Nakamura, Akinobu1 (AUTHOR), Kuwabara, Saki1 (AUTHOR), Takahashi, Yuka1 (AUTHOR), Yasui, Ayano1 (AUTHOR), Izumihara, Rimi1 (AUTHOR), Miya, Aika1 (AUTHOR), Kameda, Hiraku1 (AUTHOR), Cho, Kyu Yong1,2 (AUTHOR), Atsumi, Tatsuya1 (AUTHOR), Miyoshi, Hideaki1,3 (AUTHOR)
Zdroj: Journal of Diabetes Research. 1/19/2022, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje